ArticleCancers2022

Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy.

Tadashi Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.